The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.

On Mar. 10, the U.S. Food and Drug Administration (FDA) approved a new treatment for migraines given as a nasal spray, according to the drug’s maker, Pfizer. Zavegepant (brand name: Zavzpret), is the ...

ZAVZPRET is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine in adults Expands Pfizer’s migraine portfolio, which includes ...

The US Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults. The nasal spray zavegepant, sold as Zavzpret, may relieve pain and other bothersome ...

The Food and Drug Administration has approved a new medication to treat migraine headaches. Zavzpret (zavegepant) is a nasal spray that can help provide pain relief in as little as 15 minutes in ...

Sumatriptan is one of the most commonly prescribed medications to treat migraine attacks. As the pioneer in the triptan class ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide ...

JACKSONVILLE, Fla. – Migraine sufferers will soon have something new to try to relieve their headaches fast. Pfizer says the Food and Drug Administration has approved its new nasal spray for adults ...

Nearly 40 million Americans suffer from migraines, health experts say. The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the ...